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Notch ligands and receptors have been implicated in helper T cell (Th cell) differentiation. 
Whether Notch signals are involved in differentiation of T helper type 1 (Th1) cells, Th2 
cells, or both, however, remains unresolved. To clarify the role of Notch in Th cell differentiation, 
we generated mice that conditionally inactivate Notch signaling in mature T cells. Mice that 
lack Notch signaling in CD4
 
 
 
 T cells fail to develop a protective Th2 cell response against 
the gastrointestinal helminth 
 
Trichuris muris.
 
 In contrast, they exhibit effective Th1 cell 
responses and are able to control 
 
Leishmania major
 
 infection. These data demonstrate that 
Notch signaling is a regulator of type 2 immunity.
 
Notch signaling regulates multiple cell fate deci-
sions in multicellular organisms. There are four
mammalian Notch receptors (Notch1-4) whose
signals converge in a common pathway. Upon
binding to Jagged or Delta-like (Dll) ligands on
an adjacent cell, two sequential proteolytic
events release the intracellular domain of Notch
(ICN) allowing its translocation to the nucleus
where ICN converts the helix-loop-helix tran-
scription factor CSL/RBP-J (for CBF1/RBP-Jk
in mammals, Suppressor of Hairless in 
 
Drosophila
melanogaster
 
, Lag-1 in 
 
Caenorhabditis elegans
 
) from
a transcriptional repressor to a transcriptional
activator. In the nucleus, Mastermind-like
(MAML) proteins (1, 2) bind the ICN–CSL/
RBP-J complex and act as scaffolds to recruit
coactivators, such as p300 (3). MAML is required
for CSL/RBP-J–dependent Notch signaling,
and inhibiting the ability of MAML proteins to
recruit coactivators blocks transcriptional activa-
tion by Notch (4, 5).
Notch plays many roles in hematopoiesis
and lymphopoiesis (6). Notch1 is required for
T lineage commitment from multipotent he-
matopoietic progenitors (7, 8). Subsequently,
Notch is required for efficient transit through
the 
 
 
 
-selection checkpoint (9-11) and may
also regulate 
 
  
 
 T cell development (10, 12).
Recent data propose multiple functions for
Notch in peripheral T cells that include activa-
tion (13-15), tolerance induction (16), and
helper T cell differentiation (10, 17, 18). 
Naive CD4
 
 
 
 T cells differentiate into Th1 or
Th2 cells when stimulated through their T cell
antigen receptor. Th1 cells are characterized by
expression of the transcription factor T-bet and
produce IFN-
 
 
 
, which regulates cell-mediated
protection against intracellular microbes such
as 
 
Leishmania major
 
 (19). Th2 cells are character-
ized by expression of GATA-3 and the cytokines
IL-4, IL-5, and IL-13, which mediate protection
against parasitic helminths such as 
 
Trichuris
muris
 
 (20).
Several studies implicate Notch signaling
in CD4
 
 
 
 Th1 and Th2 cell differentiation. In
vitro studies showed that expression of different
Notch ligands on APCs have distinct effects on
CD4
 
 
 
 T cell cytokine production. For example,
Dll-1 induced IFN-
 
 
 
 (17, 18), whereas Jagged1
induced IL-4 (18). Individual Notch receptors
may also induce different responses, as ICN3 up-
regulated T-bet and IFN-
 
 
 
 expression (17),
whereas ICN1 promoted expression of GATA-3
and IL-4 (18). The involvement of Notch in Th
cell development is likely to be more complex
than in vitro experiments suggest, as mice that
conditionally inactivate Notch1 in their mature
T cells have normal immune responses (21)
and Dll ligands suppress IFN-
 
 
 
 in some circum-
stances (16). Furthermore, mature T cells that
are incapable of Notch signaling as a result of
CSL/RBP-J deletion are impaired in IL-4 but
not IFN-
 
 
 
 production in vitro (10, 18). In
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contrast, use of a 
 
 
 
-secretase inhibitor, a pharmacological in-
hibitor of Notch signaling among other pathways, inhibited
only Th1 cell differentiation (22). Thus, it has not yet been
resolved whether Notch regulates Th1 cell differentiation,
Th2 cell differentiation, or both.
To elucidate the role of Notch signaling in peripheral T
cell function, we engineered mice to conditionally express a
dominant negative MAML (DNMAML) protein that blocks
recruitment of coactivators by MAML proteins, thereby pre-
venting transcriptional activation by all four Notch receptors
(4, 5). Although T cell development and activation were
normal, IL-4 production was impaired. When challenged
with pathogens in vivo, mice that express DNMAML devel-
oped an effective Th1 cell response against 
 
L. major
 
, but
were susceptible to 
 
T. muris
 
 infection. These data show that
CSL/RBP-J–dependent Notch signaling has a specific role
in promoting type 2 immunity.
 
RESULTS AND DISCUSSION
Generation of mice
 
To block Notch signaling from all four Notch receptors,
mice were generated to express a GFP tagged DNMAML
protein in a tissue-specific manner. DNMAML contains
amino acids 13–74 of MAML1 that bind the Notch–CSL/
RBP-J complex but lacks the MAML1 sequences required to
recruit transcriptional coactivators (4). The targeting con-
struct includes a loxP flanked (floxed) PGK-Neo-tpA cassette
preventing transcriptional read-through of DNMAML1-GFP
(DNMAML) and was knocked into the ROSA26 locus (23)
(Fig. 1 A). Upon Cre expression, the PGK-Neo-tpA is ex-
cised, thereby allowing DNMAML expression and inhibition
of Notch signaling. We previously showed that DNMAML
blocks signaling by all four Notch receptors by reporter assays
(4, 5). In addition, expression of DNMAML in BM progeni-
tors blocks Notch1-dependent T cell development, and ex-
pression in splenocytes inhibits Notch2-dependent marginal
zone B cell development (24). Furthermore, DNMAML
prevents T cell development when experimentally driven
by Notch3 or Notch4 (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem20050923/DC1). To
date, we have recapitulated only Notch loss of function phe-
notypes with DNMAML and have not observed “off-
Notch” effects. Therefore, DNMAML is a pan-Notch inhib-
itor, blocking signaling from all four Notch receptors.
To study Notch function in CD4
 
 
 
 T cells, CD4-cre
transgenic mice were bred with DNMAML
 
f/
 
 
 
 mice to ob-
tain offspring that included CD4-cre 
 
 
 
 DNMAML
 
f/
 
 
 
(CCD) and CD4-cre (CC) littermate controls (Fig. 1 A).
Thymocytes from CCD mice were stained with antibodies
against cell surface markers for T cell subsets and further ana-
lyzed for GFP by flow cytometry (Fig. 1 B). GFP was de-
tectable as early as the double negative 3 stage (Fig. 1 C,
DN3; 
 
 
 
2%) and gradually increased through DN4 and in-
termediate single positive stages (Fig. 1 C, ISP). GFP expres-
sion was high by the double positive (DP) stage (
 
 
 
93%) and
reached 
 
 
 
99% in single positive (SP) thymocytes. In addi-
tion, T cell subsets were purified and further sorted on the
basis of GFP. Deletion of the floxed cassette was demon-
strated by PCR on genomic DNA from sorted T cell sub-
sets, which correlated with GFP expression (Fig. 1 C). To-
gether, these data show that CD4-cre driven expression of
the DNMAML transgene occurred in CCD mice. 
 
Normal T cell development in CCD mice
 
Thymic cellularity and absolute numbers within all T cell
subsets were normal in CCD mice (Fig. 2 A). In addition,
the percentages of CD4
 
 
 
 and CD8
 
 
 
 single positive T cells
were similar in CC and CCD mice (Fig. 2 B) Likewise, ab-
solute numbers (Fig. 2 C) and percentages of T cells were
normal in the spleen (Fig. 2 D) and lymph nodes (not de-
picted). In the periphery, 
 
 
 
98% of CD4
 
 
 
 or CD8
 
 
 
 T cells
were GFP
 
 
 
, demonstrating that single positive T cells had
not encountered any selective pressures upon transit from
the thymus to the periphery (Fig. 2 E). Peripheral T cells
from CCD mice were stained for activation markers such as
CD69, CD25, CD62L, and CD44. No differences were ob-
served in baseline expression (Fig. 2 F).
Figure 1. Generation of mice. (A) Partial restriction map of the ROSA26 
locus and targeting construct. The PGK-Neo-tpA cassette is flanked by two 
loxP sequences (black triangles). Downstream is DNMAML1-GFP-bpA (DN-
MAML). Mice expressing one knocked-in allele were crossed with CD4-cre 
mice. CD4-cre (CC) and CD4-cre X DNMAML1 (CCD). Three arrows indicate 
the position of PCR primers used to detect the deletion. SA, adenovirus 
splice acceptor; tpA, trimer of the SV40 polyadenylation sequence; bpA, 
bovine growth hormone polyadenylation sequence. (B) Thymi from CCD 
mice were stained with antibodies delineating T cell subsets and further 
analyzed for GFP expression by flow cytometry. Numbers represent the 
percentage of GFP  cells. DN, double negative; DP, double positive; ISP, 
intermediate single positive. (C) T cell subsets were sorted on the basis of 
GFP and PCR was done to detect the floxed allele (top band) or the allele 
that has undergone Cre-mediated excision (bottom band). White lines 
indicate that intervening lanes have been spliced out. 
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Loss of Notch signaling impairs Th2 cell 
differentiation in vitro
 
To characterize CD4
 
 
 
 T cell function in CCD mice, CD4
 
 
 
 T
cells were stimulated in vitro with a range of concentrations of
anti-CD3 and anti-CD28 and harvested at different time
points. There were no differences in up-regulation of activation
markers with any of the conditions compared with CC con-
trols (Fig. 3 A). CC and CCD CD4
 
 
 
 T cells underwent similar
rounds of division, as shown by CFSE dilution (Fig. 3 B).
To determine whether Notch influenced Th cell differ-
entiation, purified CD4
 
 
 
 and CD4
 
 
 
GFP
 
 
 
 T cells from CC
and CCD mice, respectively, were isolated and cultured
with irradiated APCs in the presence of anti-CD3, anti-
CD28, and IL-2 under neutral, Th1, or Th2 cell conditions.
GFP-expressing cells were previously used as a control to
show that GFP did not affect Th cell differentiation (unpub-
lished data). After 7 d of culture, cells were restimulated with
PMA and ionomycin for intracellular staining or anti-CD3
for ELISA to detect cytokine production. Intracellular stain-
ing showed a significant decrease in the percentage of cells
expressing IL-4 in CCD cultures compared with CC con-
trols under neutral and Th2-polarizing conditions (Fig. 3 C).
Although culturing under Th2 cell–permissive conditions al-
lowed more cells to differentiate into IL-4 producers, the
frequency of IL-4
 
 
 
CD4
 
 
 
 T cells from CCD mice was still
less than that observed in CC cultures. CD4
 
 
 
 T cells also ex-
hibited a decrease in the mean fluorescence intensity of IL-4
staining compared with CC controls (not depicted) correlat-
ing with a substantial decrease in IL-4 secretion (Fig. 3 D).
The ability of CCD cells to produce IL-4, albeit in reduced
quantities, in Th2 cell conditions suggests that Notch pro-
vides an important additive signal in promoting Th2 cell dif-
ferentiation, but is not an absolute requirement. 
The percentage of IFN-
 
 
 
–producing cells increased in
neutral and Th2 cell conditions compared to CC controls (Fig.
3 C). However there was no change in the percentage of IFN-
 
 
 
–producing cells in Th1 cell conditions. This was in contrast
to the increase in IFN-
 
 
 
 detected by ELISA in all conditions
and suggests that there may be differences in secretion of IFN-
 
 
 
over time (Fig. 3 D). Production of IFN-
 
 
 
 in Th2 cell con-
ditions may have been caused by the strong restimulation con-
ditions. Together, these studies demonstrated that whereas
CD4
 
 
 
 Th1 cell differentiation was intact in CCD CD4
 
 
 
 T
cells, Notch signaling was required for optimal Th2 cell differ-
entiation and expression of IL-4. However, it is unclear
whether Notch directly promotes Th2 cell differentiation. It is
possible that the absence of Notch may lead to an uncontrolled
Th1 cell response that inhibits Th2 cell differentiation.
 
CCD mice fail to mount a Th2 cell response against 
 
T. muris
 
To investigate the in vivo requirement for Notch in response
to an infection that normally elicits a protective Th2 cell re-
Figure 2. Normal T cell development in CCD mice. Graphs represent 
absolute numbers of cells within the indicated T cell subsets from (A) 
thymi or (C) splenocytes. (B) Thymi or (D) splenocytes were stained with 
antibodies against CD4 or CD8. (E) Splenocytes gated on either CD4  or 
CD8  T cells were analyzed for GFP expression. CD4-cre (CC) and CD4-
cre   DNMAML1 (CCD). (F) LN cells were stained with antibodies against 
the indicated activation markers. Gray, CC; black, CCD. Numbers on all 
flow cytometry plots represent percentage of cells within the gates. Data 
in A and C show the mean   SD (n   4).
Figure 3. Loss of Notch signaling impairs Th2 cell differentiation 
in vitro. (A) Equal numbers of CD4  T cells from CC and CCD were stimu-
lated with plate-bound anti-CD3 (2.5  g/ml) and anti-CD28 (2.5  g/ml) 
for 16 h and stained with antibodies against CD69 and CD62L. (B) Spleno-
cytes were depleted of CD8  T cells, labeled with CFSE and stimulated with 
anti-CD3 alone or anti-CD3 and anti-CD28. Cells were harvested after 4 d. 
Plots are gated on CD4  cells. (C) Purified CD4  T cells from CC and CCD 
mice were stimulated with irradiated APCs in the presence of anti-CD3, 
anti-CD28, and rIL-2 under neutral, Th1, or Th2 cell conditions and restim-
ulated PMA and ionomycin after 7 d. Intracellular cytokine expression was 
measured by flow cytometry. (D) Equal numbers of CC or CCD CD4  T cells 
were replated after 7 d and stimulated with plate-bound anti-CD3 for 24 h. 
Supernatants were collected and ELISA was performed to detect IL-4 and 
IFN- . Data are representative of five independent experiments and show 
the mean   2 SEM; *, P   0.05. Numbers on all flow cytometry plots rep-
resent the percentage of cells within the gates. 
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sponse, CCD mice were infected with 
 
T. muris
 
, a helminth
pathogen of the murine gastrointestinal tract. Immunity is de-
pendent on CD4
 
 
 
 Th2 cells that secrete IL-4 and IL-13. Ge-
netically resistant B6 mice generate a Th2 cytokine response,
which promotes goblet cell responses and control of infection
by 
 
 
 
21 d after infection (25). As expected, mesenteric lymph
node cells isolated from 
 
T. muris
 
–infected CC littermate con-
trols exhibited robust parasite-specific IL-4, -5, and -13 re-
sponses (Fig. 4 A). In contrast, 
 
T. muris
 
–infected CCD mice
displayed decreased IL-4, -5, and -13 production, whereas
IFN-
 
 
 
 production was normal compared with CC mice (Fig. 4
A). Consistent with a defect in the expression of Th2 cytokines,
infected CCD mice showed decreased levels of 
 
T. muris
 
–spe-
cific serum IgG1 but IgG2a was increased (Fig. 4 B). Further-
more, total serum IgE, another hallmark of type 2 inflamma-
tion, was dramatically lower in infected CCD mice compared
with infected CC mice. Histology of the gut revealed that al-
though infected CC mice had pronounced Th2 cytokine-
dependent goblet cell and mucin responses, there was an absence
of goblet cell responses in infected CCD mice at day 21 after
infection (Fig. 4 E). Whereas CC mice had a low worm burden
at day 21, CCD mice exhibited high worm burdens, which is
indicative of a persistent infection (Fig. 4 D). The level of infec-
tion in CCD mice was equivalent to that of immunodeficient
RAG2
 
 
 
/
 
 
 
 mice, reflecting the severely impaired immune re-
sponse in CCD mice. Furthermore, infection persisted in CCD
mice at day 32 after inoculation (Fig. 4 F). Together, these re-
sults show that Notch signaling is required for optimal Th2 cy-
tokine responses and resistance to helminth infection.
 
CCD mice are resistant to 
 
L. major
 
 infection
 
To determine whether CCD mice have a specific defect in
Th2 cell differentiation or a global defect in mounting im-
mune responses in vivo, CC and CCD mice were infected
with 
 
L. major
 
. After infection, genetically susceptible BALB/c
mice developed progressive nonhealing lesions (Fig. 5 A).
In contrast, infected CC and CCD mice efficiently con-
trolled parasite replication (not depicted) and resolved their
lesions (Fig. 5 A). To determine cytokine production, mice
were killed at day 20 after infection, and popliteal LN (PLN)
cells were restimulated with soluble 
 
L. major 
 
antigen. Con-
sistent with resistance to infection, CCD mice produced
abundant amounts of IFN-
 
 
 
 (Fig. 5 B). 
 
L. major
 
–infected
CCD mice produced undetectable levels of IL-4 compared
with low, but detectable, levels of IL-4 in PLN cultures iso-
lated from infected CC mice (Fig. 5 C). Thus, in the absence
of Notch signaling Th1-mediated immunity is preserved.
In summary, pan inhibition of Notch signaling in murine
T cells reveals a critical requirement for Notch in efficient
Th2 cell generation, both in vivo and in vitro. In the ab-
Figure 4. CCD mice fail to mount a Th2 cell response against T. muris. 
(A) At day 21, MLN cells from T. muris infected CC and CCD mice were 
stimulated with T. muris antigen for 72 h, and cytokine levels were detected by 
ELISA. (B) T. muris–specific IgG1 and IgG2a and total IgE (C) from day 21–
infected mice were determined by ELISA. (D) Worm burden at day 21 after 
infection. (E) Gut sections stained for intracellular mucin to detect goblet 
cells. (F) Worm burden at day 32 after infection. Data are representative of 
three independent experiments with at least nine mice in each group. Data 
show the mean   2 SEM; *, P   0.05; **, P   0.01.
Figure 5. CCD mice are resistant to L. major infection. (A) Lesion 
size of footpads infected with L. major. (B) PLN cells from L. major infected 
mice were restimulated with soluble Leishmania antigen for 4 d and intra-
cellular IFN-  expression was detected by flow cytometry. Cells are gated 
on CD4  T cells. Numbers represent the percentage of cells within the 
gates. (C) Supernatants were collected and levels of IL-4 were detected by 
ELISA. Data show the mean   SD (n   4).JEM VOL. 202, October 17, 2005 1041
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sence of Notch, mice were impaired in the development of a
Th2 cell response and failed to clear a parasitic infection.
Furthermore, there was no evidence of global immunodefi-
ciency, and mice were able to mount a normal Th1 cell re-
sponse and control replication of an intracellular pathogen. 
The failure to develop a sufficient Th2 cell response in
CCD mice shows that optimal Th2 cell immunity is depen-
dent on nuclear Notch signaling through CSL/RBP-J. Po-
tential molecular targets of Notch signaling in Th2 cell dif-
ferentiation include GATA-3 and IL-4. Both contain
conserved CSL/RBP-J binding sites in important regulatory
regions and the IL-4 regulatory region responded to Notch
signals in vitro (18). Alternatively, Notch may promote Th2
cell differentiation by suppressing Th1 cell differentiation.
The normal Th1 cell response in CCD mice is strong ev-
idence that Th1 cell differentiation does not require Notch
signaling through the ICN–MAML–CSL/RBP-J transcrip-
tional activation complex. This is difficult to reconcile with
overexpression data showing that ICN potentiates IFN- 
production and can bind to the T-bet promoter (17, 22).
Our data do not rule out effects of Notch signaling that are
independent of CSL/RBP-J or MAML (26), however, this
pathway is poorly understood.
Although our results do not exclude distinct roles for
Notch ligands and receptors in Th1 and Th2 cell differentia-
tion, they provide a foundation for determining the precise
molecular pathways by which Notch controls helper T cell
differentiation. Furthermore, our data suggest that Notch sig-
naling is a potential therapeutic target in diseases character-
ized by pathologic Th2 cytokine responses, such as asthma,
autoimmunity, and forms of inflammatory bowel disease.
MATERIALS AND METHODS
Generation of ROSA26 DNMAML1-GFP mice.  The gene-targeting
vector was constructed using a ROSA26 targeting vector generated by Srini-
vas et al. (23). DNMAML1 (aa13–74) was fused with GFP (DNMAML1-
GFP) (4). To generate the ROSA26–DNMAML1-GFP targeting construct,
the KpnI site in the linker between DNMAML1 and GFP was deleted by
PCR-directed mutagenesis to replace GGTACC with GGCATT. Both
GGT and GGC encode the amino acid glycine. DNMAML1-GFP was di-
gested with BglII, Klenow filled, and then digested with NotI to excise the
DNMAM1-GFP cDNA. The resulting fragment was inserted into pBigT
(23) digested with SalI, Klenow filled, and then digested with NotI. pBigT
was digested with PacI and AscI to release the entire floxed neo-tpA and
DNMAML1-GFP assembly and inserted into pROSA26PA (23) digested
with PacI and AscI. This plasmid was subsequently linearized by digestion
with KpnI and electroporated into embryonic stem cells. Approximately 180
G418- and diphtheria toxin–resistant clones were first screened by PCR us-
ing two primers—ROSA26 flanking (5  CCT AAA GAA GAG GCT GTG
CTT TGG 3 ) and splice acceptor (5  CAT CAA GGA AAC CCT GGA
CTA CTG 3 ). The size of the PCR product was  1.2 kb (27). PCR ampli-
fication was performed as follows: 93 C for 1.5 min, and then 40 cycles of
93 C for 30 s, 57 C for 30 s, followed by 65 C for 3 min. Next, 23 appropri-
ately targeted clones were verified by Southern blot analysis using EcoRV di-
gestion and hybridized with a probe recognizing the ROSA26 genomic se-
quences but not the targeting vector intended for homologous
recombination. An 11-kb fragment from the wild-type allele and a new 3.8-
kb fragment from the targeted allele were expected. Subsequently, the tar-
geted embryonic stem cell clones were microinjected into C57BL/6 (B6)
blastocysts by either the Abramson Family Cancer Research Institute Trans-
genic Mouse Core or the University of Pennsylvania Molecular Cardiology
Research Center Transgenic Core. Chimeric males were bred with B6 fe-
males and heterozygous offspring were screened by PCR and Southern blot
of tail DNA. These mice were designated as DNMAMLf/ . To express
DNMAML1-GFP in mature T cells, DNMAML1f/  mice were crossed with
CD4-Cre transgenic mice (Taconic Farms). Mice expressing one allele of
DNMAML1 were designated as CCD, whereas mice expressing only the
CD4-Cre transgene were designated as CC. Mice were backcrossed onto the
B6 background for at least five generations. CCD mice were compared with
littermate CC controls in all experiments.
B6 and RAG2 /  mice were obtained from Taconic Farms. Experi-
ments were performed according to guidelines from the National Institutes
of Health and with an approved protocol from the University of Pennsylva-
nia Animal Care and Use Committee.
In vitro T cell differentiation.  CD4 CD25  T cells from CC or CCD
mice were sorted and cultured in IMDM (Life Technologies) supplemented
with 10% heat-inactivated FBS, 100 U/ml penicillin, 100  g/ml strepto-
mycin, 2 mM L-glutamine, and 50  M 2-mercaptoethanol. T cells were
stimulated with irradiated APCs and 0.1  g/ml anti-CD3, 0.5  g/ml anti-
CD28, and 10 U/ml of recombinant human IL-2. No additional antibodies
or cytokines were added to nonpolarizing conditions. 10  g/ml anti–IL-4
and 5 ng/ml of recombinant mIL-12 (PeproTech) was added in Th1 cell
conditions. 10  g/ml anti–IL-12 and 20 ng/ml of recombinant mIL-4
(Peprotech) was added in Th2 cell conditions. Cells were differentiated for
7 d and restimulated with 50 ng/ml PMA (Sigma-Aldrich) and 500 ng/ml
ionomycin (Sigma-Aldrich) for 4 h. During the last 2 h, 2  g/ml Brefeldin
A (Sigma-Aldrich) was added. Cells were washed, fixed in 4% paraformal-
dehyde and permeabilized in 2% saponin (Sigma-Aldrich). For ELISAs,
equal numbers of viable CD4  T cells were plated in triplicate and restimu-
lated with 2.5  g/ml of plate-bound anti-CD3. After 24 h, supernatants
were collected and standard sandwich ELISA protocols were used. CFSE la-
beling was performed as previously described (14).
Flow cytometry, cell sorting, and antibodies.  After incubating with
2.4G2 hybridoma supernatant to block Fc receptors, cell suspensions were
stained with primary antibodies and washed in 2% FBS and 0.01% NaN3.
Data were acquired on FACSCalibur (Becton Dickinson) and analyzed using
FlowJo software (Tree Star). CD4  and CD4 GFP  T cells were sorted on a
MoFlo cytometer (DakoCytomation). All antibodies were obtained from BD
PharMingen except anti–IL-13 antibodies, which were from R&D Systems.
T. muris infection and antigen.  T. muris was maintained in genetically
susceptible or immunocompromised mice. Between days 35 and 42 after
infection, adult worms were isolated and cultured in RPMI 1640 (Life
Technologies) containing 500 U/ml penicillin and 500  g/ml streptomycin
for 24 h. T. muris excretory–secretory antigen was isolated at 4 and 24 h, di-
alyzed, and sterile filtered, and protein concentrations were determined by
Bradford assay. Antigen preparations were then used in lymphocyte restim-
ulations (50  g/ml). Deposited eggs were collected after 24 h of culture,
washed three times in sterile water, incubated at room temperature for 6 wk
and stored at 4 C. Mice were infected on day 0 with 150–200 embryonated
eggs, and parasite burdens were assessed on day 21 after infection. Mesen-
teric LN (MLN) cell suspensions were prepared and resuspended in IMDM
supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, 100
 g/ml streptomycin, 2 mM L-glutamine, and 50  M 2-mercaptoethanol.
Cells were plated at 4   106 cells/well and cultured alone or in the presence
of T. muris Ag for 72 h. Levels of IL-4, -5, and -13 and IFN-  were assayed
by sandwich ELISA. For histology, segments of mid-cecum were removed,
washed in sterile PBS, and fixed for 24 h in paraformaldehyde. Tissues were
processed and paraffin embedded using standard histological techniques. For
detection of intestinal goblet cells, 5- m sections were cut and stained with
hematoxylin and eosin or Alcian blue periodic acid Schiff. Analysis of para-
site-specific IgG1 and IgG2a production was performed by antigen captureNOTCH REGULATES TYPE 2 IMMUNITY | Tu et al. 1042
ELISA using biotinylated rat anti–mouse IgG1 and IgG2a (BD Biosciences).
Total serum levels of IgE were determined by ELISA (BD Biosciences).
L. major infection and antigen.   L. major parasites (MHOM/IL/80/
Friedlin) were grown in Grace’s insect culture medium (Life Technologies)
supplemented with 20% heat-inactivated FBS, 2 mM L-glutamine, 100
U/ml penicillin, 100  g/ml streptomycin. Soluble Leishmania Ag (SLA)
was prepared as previously described (28). Mice were injected in the hind
left footpad with 5   106 stationary phase promastigote parasites. Footpad
swelling was measured weekly using digital calipers (Mitutoyo), and lesion
size was determined by subtracting the size of the uninfected contralateral
footpad from the size of the infected footpad. PLN cells from infected mice
were restimulated with SLA for 4 d. Intracellular staining and ELISA were
performed as described above.
Online supplemental material.  Fig. S1 shows that DNMAML can in-
hibit Notch3 and Notch4 driven T cell development and is available at http:
//www.jem.org/cgi/content/full/jem20050923/DC1.
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